Prognostic Value of Preoperative Mean Platelet Volume and a Predictive Nomogram in Oral Squamous Cell Carcinoma Patients Based on Real-World Data

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Yan L, Chen F, Chen L, et al. Dynamic evaluation of conditional survival in patients with oral squamous cell carcinoma after surgical resection: a large-scale prospective study. Oral Oncol. 2020;104:104639. doi:10.1016/j.oraloncology.2020.10463932220811
   PubMed Web of Science ®Google Scholar
• Patel TD, Marchiano E, Chin OY, et al. Utility of surgery/radiotherapy in distant metastatic head and neck squamous cell carcinoma: a population-based approach. Otolaryngol Head Neck Surg. 2016;154(5):868–874. doi:10.1177/019459981562763726884368
   PubMed Web of Science ®Google Scholar
• Chen F, Lin L, Liu F, et al. Three prognostic indexes as predictors of response to adjuvant chemoradiotherapy in patients with oral squamous cell carcinoma after radical surgery: a large-scale prospective study. Head Neck. 2019;41:301–308.30552843
   PubMed Web of Science ®Google Scholar
• Okano S, Homma A, Kiyota N, et al. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 2021;51(2):173–179. doi:10.1093/jjco/hyaa22033290543
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
   PubMed Web of Science ®Google Scholar
• Sridharan S, Thompson LDR, Purgina B, et al. Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: a model predicting local control and vetting of the eighth edition of the American joint committee on cancer pathologic T stage. Cancer. 2019;125(18):3198–3207. doi:10.1002/cncr.3219931174238
   PubMed Web of Science ®Google Scholar
• Riess H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol. 1986;85(1):50–56. doi:10.1093/ajcp/85.1.503079628
   PubMed Web of Science ®Google Scholar
• Dincel O, Bayraktar C. Evaluation of platelet indices as a useful marker in papillary thyroid carcinoma. Bratisl Lek Listy. 2017;118:153–155.28319410
   PubMed Web of Science ®Google Scholar
• Gu ML, Yuan CJ, Liu XM, et al. Pre-treatment elevated platelet count associates with HER2 overexpression and prognosis in patients with breast cancer. Asian Pac J Cancer Prev. 2015;16(13):5537–5540. doi:10.7314/APJCP.2015.16.13.553726225707
   PubMedGoogle Scholar
• Oncel M, Kiyici A, Oncel M, Sunam GS, Sahin E, Adam B. Evaluation of platelet indices in lung cancer patients. Asian Pac J Cancer Prev. 2015;16(17):7599–7602. doi:10.7314/APJCP.2015.16.17.759926625768
   PubMedGoogle Scholar
• Li JY, Li Y, Jiang Z, Wang RT, Wang XS. Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prev. 2014;15(23):10501–10504. doi:10.7314/APJCP.2014.15.23.1050125556499
   PubMedGoogle Scholar
• Prokopowicz G, Zyczkowski M, Nowakowski K, Bogacki R, Bryniarski P, Paradysz A. Basic parameters of blood count as prognostic factors for renal cell carcinoma. Biomed Res Int. 2016;2016:8687575. doi:10.1155/2016/868757528105437
   PubMed Web of Science ®Google Scholar
• Wang X, Cui MM, Xu Y, et al. Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer. Oncotarget. 2017;8(40):68115–68122. doi:10.18632/oncotarget.1924228978101
   PubMedGoogle Scholar
• Ong HS, Gokavarapu S, Wang LZ, Tian Z, Zhang CP. Low pretreatment lymphocyte-monocyte ratio and high platelet-lymphocyte ratio indicate poor cancer outcome in early tongue cancer. J Oral Maxillofac Surg. 2017;75(8):1762–1774. doi:10.1016/j.joms.2016.12.02328063763
   PubMed Web of Science ®Google Scholar
• Liu YH, Lin YS. Platelet-lymphocyte and neutrophil-lymphocyte ratios: predictive factors of response and toxicity for docetaxel-combined induction chemotherapy in advanced head and neck cancers. J Chin Med Assoc. 2019;82(11):849–855. doi:10.1097/JCMA.000000000000017831453862
   PubMed Web of Science ®Google Scholar
• Tazeen S, Prasad K, Harish K, Sagar P, Kapali AS, Chandramouli S. Assessment of pretreatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg. 2020;78(6):949–960. doi:10.1016/j.joms.2020.01.00132027861
   PubMed Web of Science ®Google Scholar
• Yamagata K, Fukuzawa S, Uchida F, Ishibashi-Kanno N, Yanagawa T, Bukawa H. Is preoperative plate-lymphocyte ratio a predictor of deep vein thrombosis in patients with oral cancer during surgery? J Oral Maxillofac Surg. 2021;79(4):914–924. doi:10.1016/j.joms.2020.10.02433197415
   PubMed Web of Science ®Google Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence - What is it and What can it tell us? N Engl J Med. 2016;375(23):2293–2297. doi:10.1056/NEJMsb160921627959688
   PubMed Web of Science ®Google Scholar
• Sterba KR, Garrett-Mayer E, Carpenter MJ, et al. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017;127(1):127–133. doi:10.1002/lary.2615927392821
   PubMed Web of Science ®Google Scholar
• Dantas TS, de Barros Silva PG, Sousa EF, et al. Influence of educational level, stage, and histological type on survival of oral cancer in a Brazilian population: a retrospective study of 10 years observation. Medicine. 2016;95(3):e2314. doi:10.1097/MD.000000000000231426817864
   PubMed Web of Science ®Google Scholar
• Walter V, Jansen L, Ulrich A, et al. Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany. Am J Clin Nutr. 2016;103(6):1497–1506. doi:10.3945/ajcn.115.12709227146651
   PubMed Web of Science ®Google Scholar
• Mair M, Nair D, Nair S, et al. Comparison of tumor volume, thickness, and T classification as predictors of outcomes in surgically treated squamous cell carcinoma of the oral tongue. Head Neck. 2018;40:1667–1675.29734474
   PubMed Web of Science ®Google Scholar
• Rajappa SK, Maheshwari U, Jaipuria J, et al. Number of positive nodes - Current relevance in determining prognosis of oral cavity cancer after the recent AJCC staging update. Oral Oncol. 2019;90:1–5. doi:10.1016/j.oraloncology.2019.01.00130846166
   PubMed Web of Science ®Google Scholar
• Lee A, Givi B, Osborn VW, Schwartz D, Schreiber D. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma. Laryngoscope. 2017;127(9):2057–2062. doi:10.1002/lary.2651628194862
   PubMed Web of Science ®Google Scholar
• Liu F, Chen F, Huang J, et al. Prospective study on factors affecting the prognosis of oral cancer in a Chinese population. Oncotarget. 2017;8(3):4352–4359. doi:10.18632/oncotarget.1384228032596
   PubMedGoogle Scholar
• McDonald JT, Johnson-Obaseki S, Hwang E, Connell C, Corsten M. The relationship between survival and socio-economic status for head and neck cancer in Canada. J Otolaryngol Head Neck Surg. 2014;43(1):2. doi:10.1186/1916-0216-43-224422754
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126(5):582–588. doi:10.1182/blood-2014-08-53158226109205
   PubMed Web of Science ®Google Scholar
• Nagata S, Fukunaga R. Granulocyte colony-stimulating factor receptor and its related receptors. Growth Factors. 1993;8(2):99–107. doi:10.3109/089771993090469308385471
   PubMed Web of Science ®Google Scholar
• Fakhry C, Zhang Q, Nguyen-Tan PF, et al. Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer. J Clin Oncol. 2017;35(36):4057–4065. doi:10.1200/JCO.2016.72.074828777690
   PubMed Web of Science ®Google Scholar
• Xu C, Chen YP, Liu X, et al. Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy. Oral Oncol. 2017;69:99–107. doi:10.1016/j.oraloncology.2017.04.01528559028
   PubMed Web of Science ®Google Scholar
• Chen F, Lin L, Yan L, et al. Nomograms and risk scores for predicting the risk of oral cancer in different sexes: a large-scale case-control study. J Cancer. 2018;9(14):2543–2548. doi:10.7150/jca.2443130026853
   PubMed Web of Science ®Google Scholar
• Bobdey S, Balasubramaniam G, Mishra P. Nomogram prediction for survival of patients with oral cavity squamous cell carcinoma. Head Neck. 2016;38(12):1826–1831. doi:10.1002/hed.2450727227458
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang H, Wen J, et al. Nomograms forecasting long-term overall and cancer-specific survival of patients with oral squamous cell carcinoma. Cancer Med. 2018;7(4):943–952. doi:10.1002/cam4.121629512294
   PubMed Web of Science ®Google Scholar
• Pignon JP, le Maitre A, Maillard E, Bourhis J; Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14. doi:10.1016/j.radonc.2009.04.01419446902
   PubMed Web of Science ®Google Scholar
• Blanchard P, Bourhis J, Lacas B, et al. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol. 2013;31(23):2854–2860. doi:10.1200/JCO.2012.47.780223835714
   PubMed Web of Science ®Google Scholar
• Gau M, Karabajakian A, Reverdy T, Neidhardt EM, Fayette J. Induction chemotherapy in head and neck cancers: results and controversies. Oral Oncol. 2019;95:164–169. doi:10.1016/j.oraloncology.2019.06.01531345386
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695–1704. doi:10.1056/NEJMoa07102817960012
   PubMed Web of Science ®Google Scholar
• Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357(17):1705–1715. doi:10.1056/NEJMoa07095617960013
   PubMed Web of Science ®Google Scholar
• Hitt R, Lopez-Pousa A, Martinez-Trufero J, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2005;23(34):8636–8645. doi:10.1200/JCO.2004.00.199016275937
   PubMed Web of Science ®Google Scholar
• Cohen EE, Karrison TG, Kocherginsky M, et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol. 2014;32(25):2735–2743. doi:10.1200/JCO.2013.54.630925049329
   PubMed Web of Science ®Google Scholar
• Paccagnella A, Ghi MG, Loreggian L, et al. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol. 2010;21(7):1515–1522. doi:10.1093/annonc/mdp57320032123
   PubMed Web of Science ®Google Scholar
• Budach W, Bolke E, Kammers K, et al. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): a meta-analysis of randomized trials. Radiother Oncol. 2016;118(2):238–243. doi:10.1016/j.radonc.2015.10.01426589131
   PubMed Web of Science ®Google Scholar
• Zhong LP, Zhang CP, Ren GX, et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2013;31:744–751.23129742
   PubMed Web of Science ®Google Scholar
• Bossi P, Lo Vullo S, Guzzo M, et al. Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial. Ann Oncol. 2014;25(2):462–466. doi:10.1093/annonc/mdt55524401930
   PubMed Web of Science ®Google Scholar
• Chinn SB, Spector ME, Bellile EL, et al. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma. JAMA Otolaryngol Head Neck Surg. 2014;140(2):134–142. doi:10.1001/jamaoto.2013.589224370563
   PubMed Web of Science ®Google Scholar
• Patil VM, Prabhash K, Noronha V, et al. Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol. 2014;50(10):1000–1004. doi:10.1016/j.oraloncology.2014.07.01525130412
   PubMed Web of Science ®Google Scholar
• Patil VM, Noronha V, Joshi A, Banavali SD, Muddu V, Prabhash K. Preoperative chemotherapy and metronomic scheduling of chemotherapy in locally advanced oral cancers. Oncology. 2016;91(Suppl 1):35–40. doi:10.1159/00044757927463093
   PubMed Web of Science ®Google Scholar
• Kuramatsu JB, Biffi A, Gerner ST, et al. Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with Cerebellar intracerebral hemorrhage. JAMA. 2019;322(14):1392–1403. doi:10.1001/jama.2019.1301431593272
   PubMed Web of Science ®Google Scholar
• Son MBF, Murray N, Friedman K, et al.; Overcoming COVID-19 Investigators. Multisystem inflammatory syndrome in children - initial therapy and outcomes. N Engl J Med. 2021;385(1):23–34. doi:10.1056/NEJMoa2102605.34133855
   PubMed Web of Science ®Google Scholar